ABOVE: © ISTOCK.COM,
PICSFIVE
Fewer than 10 percent of dialysis patients sampled in the US showed signs of having had COVID-19 as of late July, a sign that much of the population remains susceptible to the novel coronavirus, according to one of the largest studies of its kind published Friday (September 25) in The Lancet.
Researchers studied the prevalence of antibodies against SARS-CoV-2 in a random subset of thousands of dialysis patients across the country. Their findings do not indicate exactly how many in the US are immune to the virus, as it is unclear how long immunity lasts and not every infected individual develops antibodies.
“We are still in the middle of the fight,” Eli Rosenberg, an epidemiologist at the State University of New York at Albany who was not part of the study, tells The Washington Post. “We’re all tired, and we’re all hoping for a vaccine. This shows ...